Flora Peyvandi / X
Jun 23, 2025, 11:54
Synovitis in Hemophilia: Prognostic Biomarkers Could Guide Future Therapy
Flora Peyvandi, the previous president of ISTH, recently posted on X:
“Is clear now several groups are working on Synovitis in Hemophilia and it would be good to see which biomarker could have prognostic role and a good target for future additional therapies on top of the Hemostasis factors.”
Flora Peyvandi highlights ongoing work on synovitis and potential prognostic biomarkers for future therapies.
Learn the latest new on Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action